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Shiga toxin (Stx)-producing Escherichia coli (STEC) 
strains are the most common cause of bloody diarrhea 
and the hemolytic uremic syndrome (HUS) through- 
out the world [l]. In some European countries, STEC 
strains were identified as an important cause of watery 
diarrhea [2-51. In a recent study on the prevalence of 
STEC infection in Austria, STEC strains belonging to 
the serotype 0157:H7 as well as to several non-0157 
serotypes were shown to represent the third most 
frequent bacterial cause of diarrhea in children [ 2 ] .  In 
addition, the Austrian HUS surveillance system has 
indicated that STEC strains are a cause of HUS in both 
children and adults in this country; from 1994 to 1998, 
15 of 47 reported cases of HUS were adults (data not 
shown). We therefore performed a prospective study to 
assess the relative frequency of STEC in the general 
Austrian population with community-acquired diarrheal 
disease. 
Stool specimens (one per patient) from 296 
patients with diarrhea sent to the Federal Public Health 
Laboratory in Innsbruck, Austria, for routine examina- 
tion were collected from 1 July to 31 August 1998. The 
catchment area of the laboratory covers the Austrian 
provinces of Tyrol and Vorarlberg, with approximately 
1 000 000 inhabitants. The patients consisted of 138 
males and 158 females aged from 1 month to 86.8 years 
(mean 28.2 years). 
All specimens were cultured for Salmonella, Campylo- 
barter, Shigella, Yersinia, Aerornonas, and Plesiomonas using 
standard procedures. Screening for E. coli 0157:H7 was 
performed by culture on sorbitol MacConkey agar 
(SMAC) (Oxoid, Basingstoke, UK). To screen for other 
STEC strains, enriched stool cultures in MacConkey 
broth (Oxoid) were tested for the presence of Stx by 
using a commercial enzyme-linked immunosorbent 
assay (EIA) (Premier EHEC; Meridian, Cincinnati, 
OH, USA). Direct PCR analysis from stool samples 
yielding positive EIA results was carried out from 
MacConkey broth cultures as described by Pikrard 
et a1 [5]. Immunomagnetic separa-tion (IMS) was 
performed on these EIA-positive broths as described by 
Grif et al [6]. 
STEC isolates were serotyped using standard 
procedures [7]. The presence of stx, eae and EHEC- 
hly genes was determined by using PCR procedures 
as described previously [5]. Sensitivity to antimicrobial 
agents, including cefixime, trimethoprim-sulfameth- 
oxazole, ciprofloxacin, tetracycline, gentamicin and 
ampicillin, was tested using a standard disk diffusion test 
Ninety of 296 specimens (30.4%) were positive 
for bacterial enteric pathogens. The relative frequencies 
of the isolated pathogens are shown in Table 1. Non- 
typhoidal Salmonella spp. and Campylobacter jejurzi 
accounted for 84% of the isolated pathogens (Table 1). 
Altogether, 17 of the 90 positive specimens were visibly 
bloody: three of the five patients with STEC infections, 
nine of 47 patients with salmonellosis and three of 29 
patients with campylobacter infection had bloody 
diarrhea. 
Seven of the 296 samples were positive for Stx by 
EIA. STEC colonies were identified in five of these 
specimens by using PCR for the detection of stx genes 
and IMS technique for isolation of E. coli 0157. Two 
EIA-positive specimens were negative by PCR and by 
IMS; both yielded Campylobacter jejuni. In total, STEC 
strains were isolated from 1.7% of 296 stool specimens. 
Data on the five patients who harbored STEC 
strains and on the clinical course of the disease are 
shown in Table 2 .  None of the patients with STEC 
infection required hospitalization. There were no cases 
of HUS or thrombocytopenia. 
Characteristics of five STEC isolates are shown in 
Table 3. Two of five isolates belonged to the serotype 
0157:H7/H-, and the other three to non-0157 
serotypes. All three non-0157 isolates harbored a single 
stx 2 gene, while the 0 1  57 isolates possessed a combina- 
tion of two and three distinct stx genes, respectively. All 
PI. 
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Table 1 Relative fiequency of pathogens isolated from 90 of 296 stool specimens from Austrian patients with community- 
acquired marrhea 
Organism 
No. of 
organism 
Percentage of all 
organisms 
Median age of 
patients (range) 
Salmonella spp. 47 52.2 21.0 years 
Campylobucter jejuni 29 32.2 24.5 years 
Shiga toxin-producing Escherichia coli 5 5.6 49.5 years 
Shigella sonnei 4 4.4 28.6 years 
Aeromonas hydrophilia 3 3.3 59.3 years 
Yersinia enterocolitica 2 2.3 17.0 years 
Total 90 100 28.3 
(5 months to 72.6 years) 
(17 months to 64.3 years) 
(11 months to 71.7 years) 
(7.8-44.3 years) 
(46.5-87.9 years) 
(5.2-29.2 years) 
Table 2 Summary of data on the clinical course of five patients with Shiga toxin-producing E. coli infections 
~~ ~ ~~ ~ ~ ~~ ~~ 
Diarrhea Durauon of Treatment w t h  
Patient no Sex/age (years) (bloody/severity) diarrhea (days) Fever anubioacs 
1 f/7 1 No/Moderate 3 No Fleroxacin 
2 f/69 Yes/Severe 5 No No 
3 f/ 1 Yes/Severe 10 40°C No 
4 f/3 No/Moderate 4 No No 
5 f/71 Yes/Severe 7 No Ciprofloxacin 
f. female. 
Table 3 Summary of data on five Shiga toxin (Stx)- 
producing E. coli isolates 
~~~ 
Panent EHEC- 
no. Sot1 Stx2 Stx2c Sk2e eaeA hly Serovar 
1 + -  - - + + 0118:H- 
2 + + + - + + 0157:H7 
3 - + + - + + 0157:H- 
4 + -  - - + + 0103:H2 
5 + -  - - + + 026:Hll  
five STEC strains contained eaeA and EHEC-hly genes. 
All five STEC isolates were susceptible to all anti- 
microbial agents tested (data not shown). 
The present study shows that during 2 months in 
summer 1998, STEC strains were the third most 
common bacterial pathogens in patients with diarrhea; 
they accounted for 5.6% of isolated bacterial pathogens 
and were found in 1.7% of tested stool specimens. 
However, the specimens were obtained during one 
season, and this situation may not reflect (probably does 
not reflect) the year-round pattern. The frequency of 
STEC strains in Austrian patients with diarrhea is 
comparable with that reported from Switzerland [9], 
Finland [lo], Belgium [5] and the Czech Republic [ l l ]  
where STEC strains were found in 1-2% of diarrheal 
stools submitted for routine microbiological examina- 
tion. 
Whde all five STEC isolates from patients yielded 
the eaeA gene, the only STEC strain (sorbitol-ferment- 
ing E. coli 0129:H-; positive for Stxl, Stx2, Stx 2d, 
EHEC-hly; negative for Stx2c, Stx2e) isolated from 285 
healthy volunteers submitting stool specimens during 
the same period was negative for eaeA (data not shown). 
These volunteers consisted of 86 males and 191 females 
(eight sex unknown) aged from 1 to 99 years (mean: 
46.3 years). 
An interesting finding in the study was the 
presence of three distinct stx genes, including stxl, stx2 
and stxZc, in one ofthe 0157 isolates. E. coli 0157:H7 
strains harboring a combination of these three stx genes 
were previously reported from patients in the UK [12]. 
In our study, STEC infection was found in three 
elderly patients (above 69 years of age), as compared to 
two chddren under 3 years of age. This indicates that 
routine stool examination for E. coli 0157 and non- 
0157 STEC should not be limited to specimens from 
children. 
Similarly, only three of five STEC-positive stools 
were visibly bloody, suggesting that almost one-half of 
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patients with STEC infection would be missed if only 
bloody stools were tested for STEC. In a recent paper 
deahng with 0157 (not the other serotypes), Slutsker 
et al underlined that only 60% of all 0157 strains would 
have been detected if all visibly bloody samples were 
tested, but as much as 90% if all samples of patients 
with a history of bloody diarrhea had been tested. 
Laboratories that still want to limit the screening to 
patients with bloody harrhea should ask for histories 
of bloody diarrhea when ordering stool cultures [ 131. 
For routine laboratories, the use of the SMAC 
culture method, as recommended by the Centers for 
Disease Control and Prevention, Atlanta, USA, seems 
to be satisfactory for detecting E. coli 0157:H7. 
However, this method does not detect either sorbitol- 
fermenting 0157 STEC or non-0157 STEC. Screen- 
ing for such strains should be based on the detection of 
Stx production using immunologic methods such as the 
EIA kit used in our study. The study clearly demon- 
strated the usefulness of such procedures in screening 
for STEC infection; three of the five STEC isolates 
would have been missed if our diagnostic procedure 
relied only on SMAC culture. On the other hand, the 
finding of two obviously false-positive results in the 
EIA test stresses the need for confirmation of all 
positive results by isolation of a STEC strain. 
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Neisseria cinerea, a bacterium whose bacteriological identification is difficult 
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One of the major difficulties in identifylng A? cinerea is 
the limited number of phenotypic characteristics that it 
expresses. This is perhaps why the species has under- 
gone so many changes in taxonomy, appearing and dis- 
appearing from classification at different points in time. 
In 1906, von Lingelsheim described Micrococcus cinereur 
